Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,786
archived clinical trials in
Dermatology

A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Status: Archived
Updated:  3/23/2012
mi
from
Fort Washington, PA
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Status: Archived
Updated: 3/23/2012
Philadelphia Institute of Dermatology
mi
from
Fort Washington, PA
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Status: Archived
Updated:  3/23/2012
mi
from
Nashville, TN
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Status: Archived
Updated: 3/23/2012
Dermatology Research Associates
mi
from
Nashville, TN
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Status: Archived
Updated:  3/23/2012
mi
from
Arlington, TX
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Status: Archived
Updated: 3/23/2012
Arlington Research Center
mi
from
Arlington, TX
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Status: Archived
Updated:  3/23/2012
mi
from
Houston, TX
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Status: Archived
Updated: 3/23/2012
Suzanne Bruce & Associates, PA
mi
from
Houston, TX
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Status: Archived
Updated:  3/23/2012
mi
from
San Antonio, TX
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Status: Archived
Updated: 3/23/2012
Dermatology Clinical Research Center of San Antonio
mi
from
San Antonio, TX
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Status: Archived
Updated:  3/23/2012
mi
from
Houston, TX
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Status: Archived
Updated: 3/23/2012
Center for Clinical Studies
mi
from
Houston, TX
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Status: Archived
Updated:  3/23/2012
mi
from
Salt Lake City, UT
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Status: Archived
Updated: 3/23/2012
Dermatology Research Center
mi
from
Salt Lake City, UT
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Status: Archived
Updated:  3/23/2012
mi
from
Lynchburg, VA
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Status: Archived
Updated: 3/23/2012
The Education and Research Foundation, Inc.
mi
from
Lynchburg, VA
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Status: Archived
Updated:  3/23/2012
mi
from
Norfolk, VA
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Status: Archived
Updated: 3/23/2012
Virginia Clinical Research, Inc.
mi
from
Norfolk, VA
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Status: Archived
Updated:  3/23/2012
mi
from
Spokane, WA
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Status: Archived
Updated: 3/23/2012
Premier Clinical Research
mi
from
Spokane, WA
Potential Effect of Topical Imiquimod on Atrial Ectopy in Patients With Actinic Keratosis
A Double-blind, Randomized, Placebo-controlled, 2-way Crossover Study to Assess the Potential Effect of Topically Applied Imiquimod Cream on Atrial Ectopy in Patients With Actinic Keratosis
Status: Enrolling
Updated:  4/19/2012
mi
from
Fort Meyers, FL
Potential Effect of Topical Imiquimod on Atrial Ectopy in Patients With Actinic Keratosis
A Double-blind, Randomized, Placebo-controlled, 2-way Crossover Study to Assess the Potential Effect of Topically Applied Imiquimod Cream on Atrial Ectopy in Patients With Actinic Keratosis
Status: Enrolling
Updated: 4/19/2012
Comprehensive Phase One
mi
from
Fort Meyers, FL
Click here to add this to my saved trials
Use of Epidermal Expansion System for Epidermal Grafting on Hypopigmented Skin and Surgical Wounds
A Proof of Concept Cases Series on the Use of the Epidermal Expansion System to Harvest and Place Suction Blister Epidermal Grafts on Hypopigmented Skin and Surgical Wounds
Status: Enrolling
Updated:  5/1/2012
mi
from
New York, NY
Use of Epidermal Expansion System for Epidermal Grafting on Hypopigmented Skin and Surgical Wounds
A Proof of Concept Cases Series on the Use of the Epidermal Expansion System to Harvest and Place Suction Blister Epidermal Grafts on Hypopigmented Skin and Surgical Wounds
Status: Enrolling
Updated: 5/1/2012
Laser and Skin Surgery Center of New York
mi
from
New York, NY
Click here to add this to my saved trials
mi
from
Dallas, TX
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Enhancing Hair Density With Platelet Rich Fibrin Matrix (PRFM)
Enhancing Hair Density With Platelet Rich Fibrin Matrix (PRFM)
Status: Enrolling
Updated:  5/16/2012
mi
from
New York, NY
Enhancing Hair Density With Platelet Rich Fibrin Matrix (PRFM)
Enhancing Hair Density With Platelet Rich Fibrin Matrix (PRFM)
Status: Enrolling
Updated: 5/16/2012
New York Eye and Ear Infirmary
mi
from
New York, NY
Click here to add this to my saved trials
mi
from
Santa Clara, CA
Clinical Research Facility
mi
from
Santa Clara, CA
Click here to add this to my saved trials
Comparison of Excision Versus Punch Incision in the Treatment of Epidermal Cysts
Comparison of Excision Versus Punch Incision in the Treatment of Epidermal Cysts
Status: Enrolling
Updated:  6/1/2012
mi
from
Decatur, GA
Comparison of Excision Versus Punch Incision in the Treatment of Epidermal Cysts
Comparison of Excision Versus Punch Incision in the Treatment of Epidermal Cysts
Status: Enrolling
Updated: 6/1/2012
Atlanta VA Medical Center
mi
from
Decatur, GA
Click here to add this to my saved trials
Therapeutic Study of Bevacizumab Injection Directly Inside the Keloid Tissue
A Therapeutic Trial of Intralesional Bevacizumab in Patients With Non-pedunculated Keloids
Status: Enrolling
Updated:  6/6/2012
mi
from
New York, NY
Therapeutic Study of Bevacizumab Injection Directly Inside the Keloid Tissue
A Therapeutic Trial of Intralesional Bevacizumab in Patients With Non-pedunculated Keloids
Status: Enrolling
Updated: 6/6/2012
Michael H. Tirgan, MD
mi
from
New York, NY
Click here to add this to my saved trials
Epidemiology Study of Keloid
Epidemiology Study of Keloid
Status: Enrolling
Updated:  6/6/2012
mi
from
New York, NY
Epidemiology Study of Keloid
Epidemiology Study of Keloid
Status: Enrolling
Updated: 6/6/2012
Michael H. Tirgan, MD
mi
from
New York, NY
Click here to add this to my saved trials
Web Based Investigation of Natural History of Keloid; An Online Survey of Patients With Keloid
Web Based Investigation of Natural History of Keloid; An Online Survey of Patients With Keloid
Status: Enrolling
Updated:  6/6/2012
mi
from
New York, NY
Web Based Investigation of Natural History of Keloid; An Online Survey of Patients With Keloid
Web Based Investigation of Natural History of Keloid; An Online Survey of Patients With Keloid
Status: Enrolling
Updated: 6/6/2012
Michael H. Tirgan, MD
mi
from
New York, NY
Click here to add this to my saved trials
Study of Psycho-Social Impact of Keloid
Study of Psycho-Social Impact of Keloid
Status: Enrolling
Updated:  6/6/2012
mi
from
New York, NY
Study of Psycho-Social Impact of Keloid
Study of Psycho-Social Impact of Keloid
Status: Enrolling
Updated: 6/6/2012
Michael H. Tirgan MD
mi
from
New York, NY
Click here to add this to my saved trials
Keloid Tissue Bank
Keloid Tissue Bank - Longitudinal Clinical Data Repository; A Genomic and Molecular Research to Identifying Molecular Markers and Signal Transduction Pathways in Keloid; and Correlations With the Natural History of the Disease.
Status: Enrolling
Updated:  6/9/2012
mi
from
New York, NY
Keloid Tissue Bank
Keloid Tissue Bank - Longitudinal Clinical Data Repository; A Genomic and Molecular Research to Identifying Molecular Markers and Signal Transduction Pathways in Keloid; and Correlations With the Natural History of the Disease.
Status: Enrolling
Updated: 6/9/2012
Michael H. Tirgan, MD
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  6/28/2012
mi
from
Fort Smith, AR
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
mi
from
Fort Smith, AR
Click here to add this to my saved trials
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  6/28/2012
mi
from
Santa Clara, CA
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
mi
from
Santa Clara, CA
Click here to add this to my saved trials
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  6/28/2012
mi
from
Aurora, CO
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  6/28/2012
mi
from
Bridgeport, CT
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
mi
from
Bridgeport, CT
Click here to add this to my saved trials
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  6/28/2012
mi
from
Ann Arbor, MI
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  6/28/2012
mi
from
Rochester, MN
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
mi
from
Rochester, MN
Click here to add this to my saved trials
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  6/28/2012
mi
from
Henderson, NV
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
mi
from
Henderson, NV
Click here to add this to my saved trials
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  6/28/2012
mi
from
Newark, NJ
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
mi
from
Newark, NJ
Click here to add this to my saved trials
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  6/28/2012
mi
from
Albuquerque, NM
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  6/28/2012
mi
from
Ashville, NC
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
mi
from
Ashville, NC
Click here to add this to my saved trials
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  6/28/2012
mi
from
Cleveland, OH
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  6/28/2012
mi
from
Portland, OR
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  6/28/2012
mi
from
Dallas, TX
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  6/28/2012
mi
from
Salt Lake City, UT
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Photoprovocation Testing in Subjects With Cutaneous Lupus
Photoprovocation Testing in Subjects With Cutaneous Lupus
Status: Enrolling
Updated:  7/20/2012
mi
from
Philadelphia, PA
Photoprovocation Testing in Subjects With Cutaneous Lupus
Photoprovocation Testing in Subjects With Cutaneous Lupus
Status: Enrolling
Updated: 7/20/2012
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Fresolimumab In Systemic Sclerosis
OPEN LABEL TRIAL OF ANTI-TGF-BETA MAB, FRESOLIMUMAB, IN SYSTEMIC SCLEROSIS - A PHASE ONE BIOMARKER TRIAL
Status: Enrolling
Updated:  7/25/2012
mi
from
Boston, MA
Fresolimumab In Systemic Sclerosis
OPEN LABEL TRIAL OF ANTI-TGF-BETA MAB, FRESOLIMUMAB, IN SYSTEMIC SCLEROSIS - A PHASE ONE BIOMARKER TRIAL
Status: Enrolling
Updated: 7/25/2012
Boston University School of Medicine; Rheumatology/Arthritis Center
mi
from
Boston, MA
Click here to add this to my saved trials
A Model for Implementation of Cervical Cancer Screening and HPV Vaccination the Emergency Department: a Pilot Study
A Model for the Implementation of the Cervical Cancer Screening and HPV Vaccination in the Emergency Department: a Pilot Study.
Status: Enrolling
Updated:  8/21/2012
mi
from
Norfolk, VA
A Model for Implementation of Cervical Cancer Screening and HPV Vaccination the Emergency Department: a Pilot Study
A Model for the Implementation of the Cervical Cancer Screening and HPV Vaccination in the Emergency Department: a Pilot Study.
Status: Enrolling
Updated: 8/21/2012
Sentara Norfolk General Hospital
mi
from
Norfolk, VA
Click here to add this to my saved trials
Treatment of Vitiligo With Low-energy Visible Light Laser
Treatment of Recalcitrant Forms of Vitiligo With a Low-energy 635 nm Visible Light Laser
Status: Enrolling
Updated:  9/4/2012
mi
from
Detroit, MI
Treatment of Vitiligo With Low-energy Visible Light Laser
Treatment of Recalcitrant Forms of Vitiligo With a Low-energy 635 nm Visible Light Laser
Status: Enrolling
Updated: 9/4/2012
Henry Ford Hospital Department of Dermatology. 3031 W. Grand Blvd. Suite 800
mi
from
Detroit, MI
Click here to add this to my saved trials
Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea
A Multicenter, Randomized, Controlled, Double-masked, Crossover Design Study to Compare Efficacy and Assess Safety of CD07805/47 Gel 0.5% Applied Once Daily vs Azelaic Acid Gel 15% Applied Twice Daily in Subjects With Erythema of Rosacea
Status: Enrolling
Updated:  9/12/2012
mi
from
Louisville, KY
Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea
A Multicenter, Randomized, Controlled, Double-masked, Crossover Design Study to Compare Efficacy and Assess Safety of CD07805/47 Gel 0.5% Applied Once Daily vs Azelaic Acid Gel 15% Applied Twice Daily in Subjects With Erythema of Rosacea
Status: Enrolling
Updated: 9/12/2012
Dermatology Specialists Research
mi
from
Louisville, KY
Click here to add this to my saved trials
Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea
A Multicenter, Randomized, Controlled, Double-masked, Crossover Design Study to Compare Efficacy and Assess Safety of CD07805/47 Gel 0.5% Applied Once Daily vs Azelaic Acid Gel 15% Applied Twice Daily in Subjects With Erythema of Rosacea
Status: Enrolling
Updated:  9/12/2012
mi
from
Richmond, KY
Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea
A Multicenter, Randomized, Controlled, Double-masked, Crossover Design Study to Compare Efficacy and Assess Safety of CD07805/47 Gel 0.5% Applied Once Daily vs Azelaic Acid Gel 15% Applied Twice Daily in Subjects With Erythema of Rosacea
Status: Enrolling
Updated: 9/12/2012
Melissa L.F. Knuckles MD, PSC
mi
from
Richmond, KY
Click here to add this to my saved trials
Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea
A Multicenter, Randomized, Controlled, Double-masked, Crossover Design Study to Compare Efficacy and Assess Safety of CD07805/47 Gel 0.5% Applied Once Daily vs Azelaic Acid Gel 15% Applied Twice Daily in Subjects With Erythema of Rosacea
Status: Enrolling
Updated:  9/12/2012
mi
from
Austin, TX
Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea
A Multicenter, Randomized, Controlled, Double-masked, Crossover Design Study to Compare Efficacy and Assess Safety of CD07805/47 Gel 0.5% Applied Once Daily vs Azelaic Acid Gel 15% Applied Twice Daily in Subjects With Erythema of Rosacea
Status: Enrolling
Updated: 9/12/2012
DermResearch, Inc.
mi
from
Austin, TX
Click here to add this to my saved trials
Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea
A Multicenter, Randomized, Controlled, Double-masked, Crossover Design Study to Compare Efficacy and Assess Safety of CD07805/47 Gel 0.5% Applied Once Daily vs Azelaic Acid Gel 15% Applied Twice Daily in Subjects With Erythema of Rosacea
Status: Enrolling
Updated:  9/12/2012
mi
from
Lynchburg, VA
Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea
A Multicenter, Randomized, Controlled, Double-masked, Crossover Design Study to Compare Efficacy and Assess Safety of CD07805/47 Gel 0.5% Applied Once Daily vs Azelaic Acid Gel 15% Applied Twice Daily in Subjects With Erythema of Rosacea
Status: Enrolling
Updated: 9/12/2012
The Education and Research Foundation, Inc.
mi
from
Lynchburg, VA
Click here to add this to my saved trials
24 Week Clinical Trial to Evaluate Safety and Effectiveness of a Hair Growth System to Treat Male and Female Baldness
A Randomized, Double -Blind,, Sham-Device-Controlled, Multicenter, 24-Week Clinical Trial to Evaluate the Safety and Effectiveness of the iRestore ™ Hair Rejuvenation System in the Treatment of Male and Female Androgeneticalopecia
Status: Enrolling
Updated:  9/12/2012
mi
from
Paramus, NJ
24 Week Clinical Trial to Evaluate Safety and Effectiveness of a Hair Growth System to Treat Male and Female Baldness
A Randomized, Double -Blind,, Sham-Device-Controlled, Multicenter, 24-Week Clinical Trial to Evaluate the Safety and Effectiveness of the iRestore ™ Hair Rejuvenation System in the Treatment of Male and Female Androgeneticalopecia
Status: Enrolling
Updated: 9/12/2012
TKL Research
mi
from
Paramus, NJ
Click here to add this to my saved trials
Evaluation of the Allergenicity of AMPHADASE INJECTION (Hyaluronidase Injection USP)
A Randomized, Double-Blinded, Negative- and Positive-Controlled Study for Evaluation of the Allergenicity of Amphadase® in Healthy Volunteers Using Intradermal Skin Test
Status: Enrolling
Updated:  9/17/2012
mi
from
Eugene, OR
Evaluation of the Allergenicity of AMPHADASE INJECTION (Hyaluronidase Injection USP)
A Randomized, Double-Blinded, Negative- and Positive-Controlled Study for Evaluation of the Allergenicity of Amphadase® in Healthy Volunteers Using Intradermal Skin Test
Status: Enrolling
Updated: 9/17/2012
Allergy and Asthma Research Group
mi
from
Eugene, OR
Click here to add this to my saved trials
Evaluation of the Allergenicity of AMPHADASE INJECTION (Hyaluronidase Injection USP)
A Randomized, Double-Blinded, Negative- and Positive-Controlled Study for Evaluation of the Allergenicity of Amphadase® in Healthy Volunteers Using Intradermal Skin Test
Status: Enrolling
Updated:  9/17/2012
mi
from
Lake Oswego, OR
Evaluation of the Allergenicity of AMPHADASE INJECTION (Hyaluronidase Injection USP)
A Randomized, Double-Blinded, Negative- and Positive-Controlled Study for Evaluation of the Allergenicity of Amphadase® in Healthy Volunteers Using Intradermal Skin Test
Status: Enrolling
Updated: 9/17/2012
Baker Allergy, Asthma and Dermatology Research Center
mi
from
Lake Oswego, OR
Click here to add this to my saved trials
Evaluation of the Allergenicity of AMPHADASE INJECTION (Hyaluronidase Injection USP)
A Randomized, Double-Blinded, Negative- and Positive-Controlled Study for Evaluation of the Allergenicity of Amphadase® in Healthy Volunteers Using Intradermal Skin Test
Status: Enrolling
Updated:  9/17/2012
mi
from
Portland, OR
Evaluation of the Allergenicity of AMPHADASE INJECTION (Hyaluronidase Injection USP)
A Randomized, Double-Blinded, Negative- and Positive-Controlled Study for Evaluation of the Allergenicity of Amphadase® in Healthy Volunteers Using Intradermal Skin Test
Status: Enrolling
Updated: 9/17/2012
Allergy Associates Research Center
mi
from
Portland, OR
Click here to add this to my saved trials
Evaluation of the Allergenicity of AMPHADASE INJECTION (Hyaluronidase Injection USP)
A Randomized, Double-Blinded, Negative- and Positive-Controlled Study for Evaluation of the Allergenicity of Amphadase® in Healthy Volunteers Using Intradermal Skin Test
Status: Enrolling
Updated:  9/17/2012
mi
from
Renton, WA
Evaluation of the Allergenicity of AMPHADASE INJECTION (Hyaluronidase Injection USP)
A Randomized, Double-Blinded, Negative- and Positive-Controlled Study for Evaluation of the Allergenicity of Amphadase® in Healthy Volunteers Using Intradermal Skin Test
Status: Enrolling
Updated: 9/17/2012
Rainer Center for Clinical Research, Inc
mi
from
Renton, WA
Click here to add this to my saved trials
Evaluation of the Allergenicity of AMPHADASE INJECTION (Hyaluronidase Injection USP)
A Randomized, Double-Blinded, Negative- and Positive-Controlled Study for Evaluation of the Allergenicity of Amphadase® in Healthy Volunteers Using Intradermal Skin Test
Status: Enrolling
Updated:  9/17/2012
mi
from
Seattle, WA
Evaluation of the Allergenicity of AMPHADASE INJECTION (Hyaluronidase Injection USP)
A Randomized, Double-Blinded, Negative- and Positive-Controlled Study for Evaluation of the Allergenicity of Amphadase® in Healthy Volunteers Using Intradermal Skin Test
Status: Enrolling
Updated: 9/17/2012
Asthma Inc
mi
from
Seattle, WA
Click here to add this to my saved trials
Reduced Side-Effects Of Photodynamic Therapy For The Treatment Of Moderate To Severe Acne (i-PDT)
A Pilot Clinical Trial To Reduce Side-Effects Of Photodynamic Therapy For The Treatment Of Moderate To Severe Acne
Status: Enrolling
Updated:  9/18/2012
mi
from
Boston, MA
Reduced Side-Effects Of Photodynamic Therapy For The Treatment Of Moderate To Severe Acne (i-PDT)
A Pilot Clinical Trial To Reduce Side-Effects Of Photodynamic Therapy For The Treatment Of Moderate To Severe Acne
Status: Enrolling
Updated: 9/18/2012
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials